RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares ...
LONDON, UK / ACCESSWIRE / November 1, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company targeting diseases with a high unmet ...
Announcement of Non-Discretionary Share Buyback Programme and Cancellation of Shares held in Treasury RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that ...